Eli Lilly Corp. buy BMO Capital Markets
Start price
05.02.26
/
50%
€890.00
Target price
05.02.27
-
Performance (%)
19.06%
Price
18.08.26
€1,059.6
Summary
This prediction is currently active. The prediction currently has a performance of 19.06%. This prediction currently runs until 05.02.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 0.703% | 0.703% |
| iShares Core DAX® | -0.874% | 5.325% |
| iShares Nasdaq 100 | -0.381% | 1.979% |
| iShares Nikkei 225® | -1.676% | 1.952% |
| iShares S&P 500 | -0.655% | 2.069% |
Comments by BMO_Capital_Markets for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Ratings data for LLY provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€803.70
06.11.25
06.11.25
€955.79
06.11.26
06.11.26
31.84%
18.08.26
18.08.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€690.00
20.10.25
20.10.25
€797.57
20.10.26
20.10.26
53.57%
18.08.26
18.08.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€842.00
03.07.24
03.07.24
€928.23
03.07.25
03.07.25
-21.39%
04.07.25
04.07.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€726.70
01.05.24
01.05.24
€936.94
01.05.25
01.05.25
-2.30%
02.05.25
02.05.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€666.00
07.02.24
07.02.24
€802.46
07.02.25
07.02.25
28.09%
08.02.25
08.02.25